Nuveen’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Buy
549,153
+3,867
+0.7% +$18K ﹤0.01% 2195
2025
Q4
$3M Buy
545,286
+38,076
+8% +$185K ﹤0.01% 2132
2025
Q3
$1.66M Buy
507,210
+42,066
+9% +$119K ﹤0.01% 2372
2025
Q2
$1.07M Sell
465,144
-81,270
-15% -$177K ﹤0.01% 2569
2025
Q1
$760K Hold
546,414
﹤0.01% 2753
2024
Q4
$945K Sell
546,414
-20,436
-4% -$42.4K ﹤0.01% 2736
2024
Q3
$1.14M Sell
566,850
-512,249
-47% -$1.12M ﹤0.01% 2699
2024
Q2
$2.42M Buy
+1,079,099
New +$3.14M ﹤0.01% 2290
2022
Q2
Sell
-105,426
Closed -$665K 3479
2022
Q1
$665K Buy
105,426
+2,858
+3% +$21.4K ﹤0.01% 2931
2021
Q4
$1.2M Buy
102,568
+10,194
+11% +$154K ﹤0.01% 2796
2021
Q3
$1.72M Buy
92,374
+11,952
+15% +$227K ﹤0.01% 2741
2021
Q2
$1.71M Buy
80,422
+62,821
+357% +$1.45M ﹤0.01% 2785
2021
Q1
$357K Buy
17,601
+3,373
+24% +$91.3K ﹤0.01% 3146
2020
Q4
$378K Buy
+14,228
New +$307K ﹤0.01% 3100

Other funds holding TSHA